Evidence map›Paper›PMID 36477873›Full record

ArticleEuropean heart journal. Quality of care & clinical outcomes2024

Temporal trend analysis of rheumatic heart disease burden in high-income countries between 1990 and 2019.

Utkarsh Ojha, Dominic C Marshall, Justin D Salciccioli, Becker M Al-Khayatt, Matthew Hammond-Haley, Richard Goodall, Kim L Borsky, Conor P Crowley, Joseph Shalhoub, Adam Hartley

Abstract read
In one paragraph

Article in European heart journal. Quality of care & clinical outcomes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Novel Wire-Assisted Mitral Commissurotomy Reduces Valve Crossing Time Compared to Inoue-Balloon Technique of Treating Mitral Stenosis, Randomized Controlled Trial (CROSSVal).Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Trial
  2. Article
  3. Valve biology and rheumatic heart disease pathogenesis.Nature cardiovascular research · 2026
    Review
  4. Review
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Utkarsh OjhaRoyal Brompton & Harefield Hospitals, Heart and Lung Division, Hill End Rd, Harefield, Uxbridge, UB9 6JH, UK.ORCID 0000-0001-6733-3617
Dominic C MarshallDepartment of Respiratory, National Heart and Lung Institute, Guy Scadding Building, Cale Street, London, SW3 6LY, UK.ORCID 0000-0002-3498-2511
Justin D SalciccioliDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, 15 Francis Street, Boston, MA 02115, USA.
Becker M Al-KhayattDepartment of Cardiology, East Surrey Hospital, Surrey and Sussex NHS Trusts, UK.
Matthew Hammond-HaleyDepartment of Cardiology, King's College Hospital, British Heart Foundation Centre of Research Excellence, London, WC2R 2LS, UK.
Richard GoodallSt Andrews Centre for Plastic Surgery and Burns, Chelmsford, CM1 7ET, UK.
Kim L BorskyDepartment of Plastic Surgery, Stoke Mandeville Hospital, Mandeville Rd, Aylesbury, HP21 8AL, UK.
Conor P CrowleyDivision of Pulmonary and Critical Care Medicine, Lahey Hospital and Medical Center, 41 Burlington Mall Rd, Burlington, MA, USA.
Joseph ShalhoubImperial College London and Imperial College Healthcare NHS Trust, Imperial Vascular Unit, Mary Stanford Wing, St Mary's Hospital, Praed Street, London, W2 1NY, UK.ORCID 0000-0003-1011-7440
Adam HartleyDepartment of Cardiology, National Heart and Lung Institute, Imperial College London, London, SW7 2BX, UK.

Funding

RESPIRATORY RESEARCHT32HL007633 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI George R Washko · 1985 to 2026
$14.9M
British Heart FoundationNHLBI NIH HHS T32 HL007633Wellcome Trust
6 · The paper itself

Abstract

aimsTo assesses trends in rheumatic heart disease (RHD) burden in high-income, European Union 15+ (EU15+) countries between 1990 and 2019. METHODS AND

resultsCross-sectional analysis of the incidence and mortality of RHD was conducted using data from the Global Burden of Disease (GBD) Study database. Age-standardized incidence rates (ASIRs) and age-standardized mortality rates (ASMRs) were extracted for EU15+ countries per sex for each of the years from 1990 to 2019, inclusive, and mortality-to-incidence indices (MII) were computed. Joinpoint regression analysis was used for the description of trends. Over 29 years, an overall declining trend in RHD incidence and mortality across EU 15+ nations were observed. There was significant variability in RHD incidence and mortality rates across high-income countries. However, both RHD incidence and mortality were higher among females compared with males across EU15+ countries over the observed period. The most recent incidence trend, starting predominantly after 2014, demonstrated a rise in RHD incidence in most countries for both sexes. The timing of this RHD resurgence corresponds temporally with an influx of migrants and refugees into Europe. The recent increasing RHD incidence rates ranged from +0.4% to +24.7% for males, and +0.6% to +11.4% for females.

conclusionMore than half of EU15+ nations display a recent increase in RHD incidence rate across both sexes. Possible factors associated with this rise are discussed and include increase in global migration from nations with higher RHD prevalence, host nation factors such as migrants' housing conditions, healthcare access, and migrant health status on arrival.

Indexed as

Rheumatic Heart DiseaseAdolescentCross-Sectional StudiesDatabases, FactualDeveloped CountriesEuropeFemaleHumansMaleGlobal Burden of DiseaseIncidenceMortalityRheumatic heart diseaseTrends

Identifiers

PMID36477873
PMCPMC10904725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.